Cardioprotective Activity of Selected Polyphenols Based on Epithelial and Aortic Cell Lines. A Review.
Michał OtrębaLeon KosmiderJerzy StojkoAnna Rzepecka-StojkoPublished in: Molecules (Basel, Switzerland) (2020)
Polyphenols have recently gained popularity among the general public as products and diets classified as healthy and containing naturally occurring phenols. Many polyphenolic extracts are available on the market as dietary supplements, functional foods, or cosmetics, taking advantage of clients' desire to live a healthier and longer life. However, due to the difficulty of discovering the in vivo functions of polyphenols, most of the research focuses on in vitro studies. In this review, we focused on the cardioprotective activity of different polyphenols as possible candidates for use in cardiovascular disease therapy and for improving the quality of life of patients. Thus, the studies, which were mainly based on endothelial cells, aortic cells, and some in vivo studies, were analyzed. Based on the reviewed articles, polyphenols have a few points of action, including inhibition of acetylcholinesterase, decrease in reactive oxygen species production and endothelial tube formation, stimulation of acetylcholine-induced endothelium-derived mediator release, and others, which lead to their cardio- and/or vasoprotective effects on endothelial cells. The obtained results suggest positive effects of polyphenols, but more long-term in vivo studies demonstrating effects on mechanism of action, sensitivity, and specificity or efficacy are needed before legal health claims can be made.
Keyphrases
- endothelial cells
- cardiovascular disease
- high glucose
- case control
- healthcare
- reactive oxygen species
- end stage renal disease
- health insurance
- type diabetes
- public health
- mental health
- newly diagnosed
- ejection fraction
- chronic kidney disease
- left ventricular
- prognostic factors
- heart failure
- emergency department
- atrial fibrillation
- coronary artery disease
- vascular endothelial growth factor
- risk assessment
- signaling pathway
- bone marrow
- cardiovascular events
- human immunodeficiency virus
- electronic health record
- aortic dissection
- hiv infected
- replacement therapy
- hiv testing